Sodium Chloride 0,9 % Fresenius 0,45 g Solution for Infusion
PDF Leaflet Revision Date: 28 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention and correction of fluid and electrolyte deficits.
Dosage (summary)
Dosage varies based on electrolyte loss; administered intravenously.
Special Populations
- Renal impairment
- Elderly
- Children
Pregnancy & Breastfeeding
Use with caution in pregnancy; no harmful effects expected during lactation.
Key Drug Interactions
- Corticosteroids
- NSAIDs
- Diuretics
- Lithium
Contraindications
- Hypersensitivity to sodium chloride
Common side effects
- Hypotension
- Urticaria
- Infusion site reactions
Counselling Points
- Monitor for signs of fluid overload
- Report any adverse reactions
- Ensure solution is clear before use
Serious warnings
- Risk of fluid overload
- Monitor serum sodium levels
- Caution in patients with heart failure
Important Disclaimer
The Sodium Chloride 0,9 % Fresenius 0,45 g Solution for Infusion professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
